Completed PHASE2 INTERVENTIONAL 2-arm NCT02637310

Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis

A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis

Sponsor: PharmaKing

Conditions Acute Bronchitis

Interventions N02RS1 1200mg Placebo

Updated 5 times since 2017 Last updated: Mar 29, 2016 Started: Dec 31, 2015 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Bronchitis, this trial is completed. The trial is conducted by PharmaKing and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PharmaKing

Data source: PharmaKing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.